Health and Human Services Secretary Robert F. Kennedy Jr. says he's a "big fan" of peptides and has taken them himself. Whether the compounds are safe and proven is a different question entirely.
The Trump Administration is actively moving to make wellness peptides marketed for healing wounds, anti-aging and building muscle more accessible.
The Food and Drug Administration announced this week that it will lift restrictions that the Biden administration placed on them that had barred compounding pharmacies from making them. To facilitate this, a two-day advisory committee meeting is set for late July to evaluate seven compounds, including BPC-157, with a second panel to address five additional peptides by February 2027.
The move follows months of political pressure. Health and Human Services Secretary Robert F. Kennedy Jr., who told podcaster Joe Rogan in February that he is a "big fan" of peptides and has taken them himself, argues the Biden administration overstepped and drove users toward a black market. Kennedy called the reclassification effort a “long-overdue action to restore science, accountability and the rule of law.”
For the clinics, telemedicine platforms and med spas already marketing these injections, this is welcome news. For patients considering them, it raises an important question: Does a potential loosening of restrictions mean these compounds are safe and proven?
